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Background: Human leukocyte antigen (HLA) loci have been implicated in several neurodevelopmental disorders
in which language is affected. However, to date, no studies have investigated the possible involvement of HLA loci
in specific language impairment (SLI), a disorder that is defined primarily upon unexpected language impairment.
We report association analyses of single-nucleotide polymorphisms (SNPs) and HLA types in a cohort of individuals
affected by language impairment.
Methods: We perform quantitative association analyses of three linguistic measures and case-control association
analyses using both SNP data and imputed HLA types.
Results: Quantitative association analyses of imputed HLA types suggested a role for the HLA-A locus in
susceptibility to SLI. HLA-A A1 was associated with a measure of short-term memory (P = 0.004) and A3 with
expressive language ability (P = 0.006). Parent-of-origin effects were found between HLA-B B8 and HLA-DQA1*0501
and receptive language. These alleles have a negative correlation with receptive language ability when inherited
from the mother (P = 0.021, P = 0.034, respectively) but are positively correlated with the same trait when paternally
inherited (P = 0.013, P = 0.029, respectively). Finally, case control analyses using imputed HLA types indicated that
the DR10 allele of HLA-DRB1 was more frequent in individuals with SLI than population controls (P = 0.004, relative
risk = 2.575), as has been reported for individuals with attention deficit hyperactivity disorder (ADHD).
Conclusion: These preliminary data provide an intriguing link to those described by previous studies of other
neurodevelopmental disorders and suggest a possible role for HLA loci in language disorders.
Keywords: Specific language impairment (SLI), HLA, Neurodevelopmental disorders, Genetic associationBackground
The human major histocompatibility complex on chromo-
some 6 contains many highly polymorphic genes involved
in immune function [1,2], notably the human leukocyte
antigen (HLA) genes. Specific HLA alleles have been as-
sociated with more than 100 traits, including striking
association with autoimmune diseases [3,4]. Given the
identification of possible abnormal immune responses
observed in participants with autism (for example, anti-
bodies which react to proteins found in the central ner-
vous system [5]) and similarities between schizophrenia* Correspondence: dianne@well.ox.ac.uk
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stated.and diseases with established HLA associations [6], several
studies have examined the possible involvement of HLA
loci in neurodevelopmental disorders. Such investiga-
tions have typically targeted autism and attention deficit
hyperactivity disorder (ADHD) as well as psychiatric dis-
orders such as schizophrenia. Specific alleles (please see
a note regarding the terminology in the Methods section)
of HLA-DRB1, including DR4 and DR12, have been asso-
ciated with autism, ADHD, and schizophrenia, although
these findings have not always replicated within or between
disorders. In addition, association between the A2 allele of
the HLA-A gene and autism has been reported [7].
Pertinent to the present study is the suggestion that
autoimmunity may also be involved in neurodevelop-
mental disorders that include language deficits: a positivetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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with Landau-Kleffner syndrome, a disorder characterized
by aphasia and epileptic seizures [8]. Autoantibodies that
react with brain tissue have been found in a relatively large
number of children with an atypical variant of Landau-
Kleffner syndrome and autism compared with controls.
Such antibodies were also found in children affected
by other neurological disorders, albeit less frequently [9].
Another study found antibodies that bound to rodent
Purkinje cells in the serum of a mother with a child with
specific language disorder, a child with autism, and a child
with typical development. When this serum was injected
in pregnant mice, the mouse pups had reduced explora-
tory behavior and impaired motor coordination [10]. The
HLA region has also been implicated in a linkage study of
dyslexia [11].
Specific language impairment (SLI) is diagnosed when a
child has problems with the acquisition of language but
shows normal development in all other areas [12]. SLI is a
heterogeneous and complex disorder with a strong genetic
component [13]. Several linkage regions and genes have
been identified in genetic studies of SLI [14-17]. One gene
in particular, CNTNAP2 (contactin associated protein-
like 2), has been implicated in SLI, autism, and ADHD
[16,18,19]; in the context of SLI, this gene was associated
across three language-related measures: nonword repeti-
tion (NWR) scores, Clinical Evaluation of Language Fun-
damentals (CELF) expressive language scores (ELS), and
CELF receptive language scores (RLS) [16], all of which
have been employed in the present study. The product of
the CNTNAP2 gene is involved in forming the gaps in the
myelin sheath [20], which is interesting in the context of
the autoimmune reaction to myelin detected in children
with Landau-Kleffner syndrome. Though clinically dis-
tinct, SLI, autism, and ADHD have some phenotypic simi-
larities; language may be impaired in all three disorders
[21-23]. The core linguistic deficit in SLI may not be
the same as the one in autism or ADHD. Children with
ADHD and children with SLI may differ in their conversa-
tional profiles. Whereas children with SLI tend to have
more limitations in the areas of lexical diversity, sentence
length, and morphosyntactic development, children with
ADHD differ from children with normal language in their
utterance formulation (that is, in the number of pauses,
repetitions, revisions, or other such elements), and chil-
dren with autism typically have pragmatic impairments
[24-26]. Nevertheless, some children with autism exhibit
language impairments that are more frequently observed
in children with SLI and vice versa [22]. Given the genetic
and phenotypic overlaps between SLI, autism, and ADHD
and the HLA linkage and associations identified in studies
of dyslexia, autism, and ADHD, we decided to investigate
the possible involvement of HLA loci in SLI. Our initial
investigations involved the completion of quantitative andcase-control association analyses with single-nucleotide
polymorphisms (SNPs) across the HLA region. We went
on to impute HLA types from SNP array data and tested
for association with language impairment, again within
quantitative-trait and case-control association models.
Methods
Participants
The SLI cohort in this study included families from five
centers across the UK—the Newcomen Centre at Guy’s
Hospital (London) (now called the Evelina Children’s
Hospital), the Cambridge Language and Speech Project
(CLASP), the Child Life and Health Department at the
University of Edinburgh, the Department of Child Health
at the University of Aberdeen, and the Manchester Lan-
guage Study—as described in previous SLI Consortium
(SLIC) studies [14,17,27-29]. In addition, this study in-
cluded 49 newly-collected families from the Evelina
Children’s Hospital cohort which had not been included in
previous SLIC studies. All individuals were self-reported
white British. These collections were approved by the rele-
vant local ethics committees, and all subjects provided in-
formed consent for participation in this study. All SLIC
families were ascertained on the basis of a single proband
with expressive and/or receptive language skills at least 1.5
standard deviations (SDs) below that expected for their
age (population mean = 100, SD = 15) and Wechsler
Intelligence Scale for Children (WISC) Perceptual Orga-
nization Index (a composite score of the non-verbal
subtests Picture Completion, Picture Arrangement, Block
Design, and Object Assembly) of more than 77.5 (1.5 SD
below that expected for their age). Probands did not have
a diagnosis of autism or hearing impairment. DNA and
phenotypic data were collected from all children regard-
less of linguistic ability, and DNA was collected from all
available parents. All probands met the above criteria for
SLI, but we did not exclude probands on the basis of a
diagnosis of ADHD or dyslexia alone, given the high de-
gree of co-occurrence of SLI and ADHD or dyslexia. How-
ever, for some of our SLIC samples, data were available for
the presence of hyperactivity, coordination, and reading
problems. From this, we estimate that approximately one
third of our SLIC samples showed some evidence of ADHD
or developmental coordination disorder and that approxi-
mately one half of our probands had reading problems.
SNP arrays and quality control measures
SNP data were generated for both SLIC and control
samples by using Illumina Omni-Express (version 12.1)
genome-wide SNP arrays (Illumina, San Diego, CA, USA).
Prior to HLA imputation, all genotypes were filtered on
the basis of several quality-control measures as suggested
in [30]: samples with a genotype success rate below 95%
or a heterozygosity rate ±2 SD from the mean were
Table 1 Descriptive statistics for the language
phenotypes of the children in our sample
Trait NWR ELS RLS
Mean 90.858 77.812 88.005
Standard deviation 19.406 16.742 17.354
Median 94 76 87
Minimum 55 45 50
Maximum 136 131 138
ELS, expressive language score; NWR, nonword repetition; RLS, receptive
language score.
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less than 1%, or a Hardy-Weinberg equilibrium P value of
less than 0.001. Inheritance data within families were used
to exclude SNPs and samples with an error rate of greater
than 1%. Control data (CEU, YRI, CHB, JPT, Hapmap re-
lease #3) were employed through a principal component
analysis to exclude individuals with divergent ancestry
(although some minor differences due to population sub-
structure may still be present), and samples with known
chromosomal rearrangements or discordant sex informa-
tion (where appropriate) were removed. Genotypes were
compared with existing SNP genotype data for 700 indi-
viduals across 734 SNPs, yielding an estimated genotype
error rate of 0.00967.
Imputation and grouping of HLA types
HLA alleles for HLA-A, HLA-B, HLA-C, HLA-DQA1,
HLA-DQB1, and HLA-DRB1 were imputed from SNP
data across chromosome 6 with HLA*IMP:01 [31].
HLA*IMP:01 employed 208 SNPs from across chromo-
some 6 which it deems informative to impute HLA types
for the six HLA loci. The HLA*IMP algorithm first selects
informative SNPs that were typed in both the reference
and the sample sets. The client program performs sev-
eral quality-control measures on the SNP data. Geno-
types are aligned and phased within HLA*IMP by using
a reference panel (HapMap3 CEU b36). The HLA types
are then imputed on the HLA*IMP server.
HLA*IMP provides a probability value Q (maximum of
the posterior probability distribution, which includes all the
probabilities assigned to each allele of a given HLA gene)
that may be used as a quality measure. We kept imputa-
tions with a Q score of 0.9 or above. The resolution of the
HLA*IMP imputations is a four-digit HLA type. To reduce
the number of alleles in the analyses while still retaining
antigen-specificity distinctions, we grouped the HLA types
according to the HLA Dictionary, based on their sero-
logical equivalence [32], as previously employed in similar
studies [33]. For simplicity, the serological groups will here-
after be referred to as alleles. HLA-DQA1 types were not
grouped, since HLA-DQA1 types were not included in the
HLA Dictionary, and they are presented with their four-
digit designations (for example, HLA-DQA1*0501). Alleles
that otherwise did not have a WHO assignment were not
used in this study.
A comparison of the imputations for a subset of the
People of the British Isles (POBI) individuals who were
typed for several HLA loci through direct genotyping (sam-
ples included in [34]) showed a concordance rate of 91.2%
between the genotypes and imputations with Q ≥ 0.9 (122
alleles across all six loci were used in this comparison). It
should be noted that the samples were genotyped and not
serotyped, and a two-digit resolution for the HLA types
was used.Quantitative analyses
Three linguistic test scores were investigated by quantita-
tive association analyses. Age-normalized composite scores
of expressive and receptive language ability were obtained
from the revised version of the Clinical Evaluation of Lan-
guage Fundamentals (CELF-R) [35]. These scores provide
a broad overview of two main components of linguistic
ability and have previously been shown to represent con-
sistent phenotypes for quantitative linkage and association
analyses of SLI [14,16]. A 28-item NWR test [36] was also
administered. NWR may be used as a measure of phono-
logical short-term memory (the ability to retain verbal or
speech-based information for a short period of time), and
it has also been proposed to be an endophenotype of SLI
[37], although its sensitivity is disputed by some [38].
These measures were collected for all SLIC children re-
gardless of language ability. Table 1 contains the descrip-
tive statistics for the language traits of the sample used in
this study, and the distribution plots can be found in Add-
itional file 1. For an extensive description of the cohort sta-
tistics, see [14,17,27,29]. Age-normalized scores were used
for all samples, regardless of language ability. Nine hun-
dred fourteen individuals from 280 language-impaired
families were included in the quantitative analyses of both
SNP data and HLA types. SNP association analyses were
performed using a likelihood-ratio test (“assoc” function)
in MERLIN [39]. The analyses included 6,725 SNPs
encompassing the HLA region on chromosome 6 (25-35
MB, hg18). Since the imputed HLA types were multi-
allelic, quantitative transmission disequilibrium test
(QTDT) [40] was used for the family-based quantitative
association analyses of these data. The orthogonal “within
family” model was used, and the tests considered environ-
mental, polygenic, and additive major gene effect variance
components. Three tests were run: a general QTDT and
two tests of parent-of-origin effects (maternal and pater-
nal). We also tested for significant differences between the
maternal and paternal associations in QTDT.
Case-control analyses
In addition to quantitative tests of association, we per-
formed case-control analyses to compare HLA allele
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tion controls. These analyses included 241 independent
probands and 566 population controls. To control for
non-independence, case-control analyses used only the
proband from each family, even if the sibling met criteria
for SLI (as described in the Participants section). The
population controls came from the POBI study [34] and
an Oxfordshire study of gene expression in primary im-
mune cells [41] and were included in the principal compo-
nent analysis mentioned earlier. All control samples were
from adults who were unselected in terms of their lan-
guage performance, and we had no phenotype data for
them. SNP-based case-control analyses were performed
using the standard case-control analysis based on a chi-
squared test (“assoc” function) in PLINK [42]. SNP-based
analyses included 6,725 SNPs encompassing the HLA
region on chromosome 6 (25-35 MB, hg18). Since the
imputed HLA-types were multi-allelic, we used a Fisher’s
exact test calculator [43] to generate P values for differ-
ences in allele counts between cases and controls.
Calculation of relative risks for HLA data
Relative risks were calculated for HLA alleles that were
significantly associated with increased or decreased risk in
the case-control analysis. Samples with one or more un-
known alleles (at a given locus) were excluded from these
analyses. The calculations of relative risks and confidence
intervals were performed by using the method described
in [44].
Multiple testing of SNP and HLA data
In the quantitative analyses of HLA types, empirical P
values were obtained for each of the tests performed with a
permutation procedure implemented in QTDT using 1,000
permutations. QTDT performs Monte-Carlo permutations
providing a P value with a built-in adjustment for multiple
testing which is specific to the dataset in hand. Associa-
tions with empirical P values below 0.05 are marked by aTable 2 Results of the quantitative transmission disequilibriu
HLA allele General QTDT Maternal pa
HLA-A A1 0.004 (NWR)+a 0.026 (ELS)+
HLA-A A3 0.006 (ELS)−a
HLA-B B8
HLA-C Cw6
HLA-C Cw8 0.039 (ELS)+a
DQA1*0301
DQA1*0501
DRB1 DR7 0.019 (RLS)+
DRB1 DR17
Associations with P ≤0.05 are shown. The + and − symbols indicate the direction of
aAssociations with empirical P ≤0.05 in the permutation analyses. ELS, expressive la
disequilibrium test; RLS, receptive language score.superscript ‘a’ in Table 2. This method was chosen, as
QTDT may test different numbers of alleles in each ana-
lysis, depending on the availability of informative families,
which is taken into account through the built-in adjust-
ments. In the case-control analysis of HLA-types as well as
all the analyses which used the SNP data, the false discov-
ery rate (FDR) method [45] was used to control for the
proportion of false positives among the significant results.
QVALUE, which uses the model proposed by Storey [46],
was used for generating FDR q values for the alleles of each
HLA locus separately (with λ = 0). The q values for SNP
associations and HLA allele associations with P values
below 0.05 are reported in the Results section below. This
approach is particularly suitable for analyzing a large num-
ber of alleles, as using a Bonferroni correction in such cases
would be highly over-conservative, resulting in a great re-
duction in power [47].
Results
Quantitative association analysis with SNP data
The most associated SNPs in the analyses of the ELS
and RLS traits (rs1319972, P = 7.72 × 10−5 and rs1233579,
P = 0.00026, respectively) did not fall within coding
genes. The most associated SNP in the NWR analysis
(rs17266491) fell within the gene LRRC16A (leucine rich
repeat containing 16A) (P = 6.86 × 10−5) and repre-
sented the most significant result of the SNP-based
quantitative analyses. Across the six HLA genes (HLA-
A, HLA-B, HLA-C, HLA-DQA1, HLA-DQB1, and HLA-
DRB1), the most associated SNP was rs3823342 in
HLA-A. This was found with ELS (P = 0.01173) and
had a q value of 0.205. Investigation of multiple testing
using the FDR method yielded minimum q values of
0.057, 0.064, and 0.155 for the ELS, RLS, and NWR
traits, respectively. These data indicate that between
5.7% and 15.5% of the highest-ranking SNP-based asso-
ciations, of which there were 40 for ELS, 46 for RLS,
and 6 for NWR, are likely to represent false positives.m test analyses
rent-of-origin analysis Paternal parent-of-origin analysis
0.021 (RLS)−a 0.013 (RLS)+a
0.019 (ELS)−a
0.03 (ELS)− 0.011 (RLS)−a
0.034 (RLS)−a 0.029 (RLS)+
0.028 (RLS)−
the association, and the associated trait is listed next to the P value.
nguage score; NWR, nonword repetition; QTDT, quantitative transmission
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can be found in Additional file 1.
Case-control association analysis with SNP data
The SNP with the strongest evidence for association
(rs9467476, with P = 0.00027) fell within the gene
LRRC16A. There were five other SNPs within that gene
with P ≤0.01, but no other association trends were found.
This association did not survive multiple testing: the low-
est q value was 0.671, indicating a particularly high false-
positive rate in these analyses. Across the six HLA genes
examined, the most highly associated SNP was rs1058026
in HLA-B (P = 0.001885). A regional association plot for
the case-control analysis can be found in Additional file 1.
Quantitative association analyses with HLA data
In total, nine alleles in HLA-A, HLA-B, HLA-C, HLA-
DQA1, and HLA-DRB1 showed marginal association
(nominal P ≤0.05). Furthermore, 8 of these 13 associations
survived multiple testing, with an empirical P ≤0.05, as
assessed by a permutation procedure. The most significant
association was seen with allele A1 of the HLA-A gene,
which was associated with increased performance on the
NWR test (nominal P = 0.004, empirical P = 0.017). In
contrast, the A3 allele of HLA-A was associated with lower
ELSs (nominal P = 0.006, empirical P = 0.016). A marginal
association was also found between the Cw8 allele of
HLA-C, and higher ELSs (nominal P = 0.039, empirical
P = 0.048).
The parent-of-origin analyses highlighted effects of
particular interest for the B8 allele of the HLA-B gene
(minimum nominal P = 0.013, empirical P = 0.029) and
HLA-DQA1*0501 (minimum nominal P = 0.029, empir-
ical P = 0.057). Both these alleles were associated with
lower RLS when inherited from the mother and higher
RLS when inherited from the father. Note, however, that
the paternal parent-of-origin effects for HLA-DQA1*0501
did not survive the permutation procedure. Borderline
associations were also observed for the paternal alleles
Cw6 of HLA-C with ELS (nominal P = 0.019, empiricalTable 3 Results of the case-control association analysis
HLA allele Number of
alleles counted
in probands
Number of
alleles counted
in controls
Frequency
in probands
Frequency
in control
HLA-DRB1
DR10
395 912 0.018 0.002
HLA-
DQA1*0301
453 1078 0.174 0.231
HLA-B B57 443 1055 0.023 0.047
HLA-DRB1
DR4
395 912 0.108 0.158
HLA-DRB1
DR12*
395 912 0.005 0.02
Associations with P ≤0.05 are shown. aThe P value for DR12 was 0.050339 but was iP = 0.037) and HLA-DQA1*0301 with RLS (nominal P =
0.011, empirical P = 0.035), which were associated with
lower language scores. Table 2 includes all quantitative as-
sociations with P ≤0.05.
Case-control association analyses with HLA data
In total, there were three HLA-DRB1 alleles (DR4, DR10,
and DR12) with nominal P ≤0.05. The DR10 allele of
HLA-DRB1 showed a significantly increased allele fre-
quency in probands with language impairment compared
with controls (nominal P = 0.004), whereas the DR4 and
DR12 alleles of HLA-DRB1 (nominal P = 0.02 and nominal
P = 0.05, respectively) were less frequent in probands with
language-impairment than controls indicating a protective
risk. FDR analyses indicated that two of these three associ-
ations are likely to represent true positives (the q value for
the least associated allele was 0.235). The DR10 allele had
a particularly strong relative risk of 2.575 (95% confidence
interval: 1.773 ≤ relative risk ≤ 3.737), whereas those for
DR4 and DR12 were both below 1.0 and the 95% confi-
dence intervals for DR4 did not encompass 1.0. HLA-
DQA1*0301 (nominal P = 0.014) and the B57 allele of
HLA-B (nominal P = 0.029) were also both significantly
less frequent in probands with language-impairment com-
pared with controls. FDR analyses of DQA1*0301 yielded
a low q value (0.098), bolstering confidence in its authenti-
city. In contrast, FDR indicated that the association with
HLA-B B57 is likely to represent a false positive (q value of
0.911). The relative risk values for DQA1*0301 and B57
were both below 1.0 and had significant 95% confidence
intervals that did not encompass 1.0. Table 3 includes
case-control associations with P ≤0.05 and their relative
risks and confidence intervals. Figure 1 includes allele fre-
quencies in probands with language impairment and con-
trols for HLA loci tested.
Discussion
SLI is a complex and heterogeneous neurodevelopmen-
tal disorder that affects language development in chil-
dren. HLA associations have been reported for others
Fisher’s
exact
test P
Relative
risk
95% confidence
interval – lower
boundary
95% confidence
interval – upper
boundary
Effect
0.004 2.575 1.773 3.737 Risk
0.012 0.753 0.59 0.961 Protective
0.029 0.541 0.303 0.963 Protective
0.02 0.692 0.510 0.939 Protective
0.05 0.333 0.09 1.243 Protective
ncluded here since the P values were rounded up to the third decimal place.
Figure 1 Human leukocyte antigen (HLA) allele frequencies in
specific language impairment (SLI) probands and controls.
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and phenotypic overlap with SLI. We investigated the
possible involvement of HLA loci in SLI using several
approaches: quantitative and case-control association
analyses both with SNPs in and around the HLA region
and with HLA types.
QTDT analyses of HLA-type data identified risk and
protective alleles with regard to the three measured traits,
and these findings did survive multiple testing. HLA-A A1
was the most highly positively correlated allele (with
NWR, nominal P = 0.004, empirical P = 0.017), and HLA-
A A3 was the most highly negatively correlated allele (with
ELS, nominal P = 0.006, empirical P = 0.016), thus impli-
cating the HLA-A locus in susceptibility to SLI.
We also found interesting evidence of parent-of-origin
effects. In particular, the HLA-B B8 allele and HLA-
DQA1*0501 are negatively correlated with RLS when inher-
ited from the mother but positively correlated with the
same trait when paternally inherited. Parent-of-origin ef-
fects have been reported with regard to the involvement of
HLA alleles in neurological disorders such as multiple scler-
osis [48], and in this respect it is interesting to find such an
effect in SLI. The associations with B8 in both parent-of-
origin effects analyses remained significant following the
permutation procedure. Interestingly, HLA-B has been im-
plicated in schizophrenia; however, the increase in risk was
the result of matching HLA-B genotypes in the mother and
the child [33]. While the association detected in our study
is with a specific allele, it is interesting to note that the asso-
ciation is correlated with negative test scores only when the
allele is inherited from the mother (so there is a matching
of at least one allele between the mother and the child).
Although many of the associations observed in this
study were of borderline significance, it is interesting to
note that the identified association trends are supported
by studies of related neurodevelopmental disorders. In
an ADHD study of a Chinese cohort [49], the DR10 al-
lele of HLA-DRB1 was found to be significantly more
frequent in children with ADHD than in controls, as is
the case with the probands with SLI in our study. This
result translates to a particularly high relative risk of
2.575, with a 95% confidence interval of 1.773 ≤ relative
risk ≤ 3.737, and was supported by FDR analyses. Simi-
larly, Wang and colleagues [49] reported that the DR12
allele of HLA-DRB1 was significantly more frequent in
controls than in cases with ADHD, a trend which again
is replicated in our study. The trend of association found
between the DR4 allele of HLA-DRB1 in our probands
with language-impairment matches that described by
Wright and colleagues [50] in a study of schizophrenia
but is the opposite of that observed in ADHD by Odell
and colleagues [51]. Note, however, that this ADHD asso-
ciation was not replicated in the Chinese study previously
mentioned [49]. Interestingly, the HLA-DRB1 case-control
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the opposite to previously described association trends of
HLA alleles with autism (albeit not always significantly
so). The DR4 allele was associated with autism [52,53] but
is significantly less frequent in probands with SLI than in
controls (Table 3, Figure 1). DR13 and DR14 (grouped to-
gether) have been negatively associated with autism [52],
which is, again, the opposite trend to the one observed
here (Figure 1, frequency in probands with language-
impairment: 0.14 and 0.03; frequency in controls: 0.11 and
0.02, for DR13 and DR14, respectively). Although these
differences were not even nominally significant in SLI,
they may suggest that if HLA alleles play a role in both
SLI and autism, the mechanism itself may be different.
Although quantitative and case-control SNP-based
analyses consistently identified associations within the
LRRC16A gene, none of the SNP-based analyses found
strong association trends within HLA loci. Furthermore,
the FDR q values obtained for SNP-based associations
were all greater than 0.05, indicating a high false-positive
rate. Nonetheless, it should be noted that one might not
expect to find a direct correlation between SNPs in HLA
genes and effects mediated by HLA types, because of the
high degree of variation in the HLA region.
Conclusions
The results of this study suggest a potential involvement
of HLA loci in SLI. Quantitative association analyses
highlighted HLA-A and parent-of-origin effects for HLA-
B, whereas case-control analyses implicated HLA-DRB1
alleles. Further, larger-scale studies will be required to
replicate these findings. The relatively small sample sizes
employed are reflected by nominal P values. Since our
analyses used imputed HLA alleles and since no HLA
associations have been previously reported for SLI, we
did not confine ourselves to testing only a subset of the
HLA alleles, and, consequently, we performed a rela-
tively large number of tests. Nonetheless, we believe that
association testing and imputation of HLA types provide
a cost-effective way of studying the involvement of
immune-related genes in neurodevelopmental disorders.
The preliminary data presented here provide an intri-
guing link to those described by previous studies of
other neurodevelopmental disorders suggesting a pos-
sible role for HLA loci in language disorders.
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